Kiriyama M et al. |
Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. |
1997 |
Br. J. Pharmacol. |
pmid:9313928
|
Minami T et al. |
Absence of prostaglandin E2-induced hyperalgesia in NMDA receptor epsilon subunit knockout mice. |
1997 |
Br. J. Pharmacol. |
pmid:9113374
|
Minami T et al. |
Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2. |
1997 |
Br. J. Pharmacol. |
pmid:9375954
|
Trist DG et al. |
The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase. |
1989 |
Br. J. Pharmacol. |
pmid:2466517
|
Hay DW et al. |
Relative contributions of direct and indirect mechanisms mediating endothelin-induced contraction of guinea-pig trachea. |
1993 |
Br. J. Pharmacol. |
pmid:7507780
|
Ito S et al. |
Evaluation of ZK110841 and AH6809, an agonist and an antagonist of prostaglandin DP-receptors on human platelets, with a PGD2-responsive cell line from bovine embryonic trachea. |
1990 |
Br. J. Pharmacol. |
pmid:2158830
|
Kane CJ et al. |
Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-γ agonists. |
2011 |
Brain Behav. Immun. |
pmid:21376806
|
Oishi Y et al. |
The roles of prostaglandin E2 and D2 in lipopolysaccharide-mediated changes in sleep. |
2015 |
Brain Behav. Immun. |
pmid:25532785
|
Kamauchi S and Urade Y |
[Hematopoietic prostaglandin D synthase inhibitors for the treatment of duchenne muscular dystrophy]. |
2011 |
Brain Nerve |
pmid:22068479
|
Nagata N and Urade Y |
[Sleep-wake regulation by prostaglandin D2 and adenosine]. |
2012 |
Brain Nerve |
pmid:22647469
|
Yamaguchi K and Hama H |
Separation of periventricular dopaminergic and alpha-adrenergic systems from the vasopressin-secreting mechanisms activated by prostaglandin D2. |
1991 |
Brain Res. |
pmid:1665382
|
Hortobágyi L et al. |
Adaptation of the hypothalamic blood flow to chronic nitric oxide deficiency is independent of vasodilator prostanoids. |
2007 |
Brain Res. |
pmid:17161389
|
Kimura H et al. |
Modulatory effects of prostaglandin D2, E2 and F2 alpha on the postsynaptic actions of inhibitory and excitatory amino acids in cerebellar Purkinje cell dendrites in vitro. |
1985 |
Brain Res. |
pmid:2859088
|
Nojima H et al. |
Arachidonic acid and prostaglandin D2 cooperatively accelerate desensitization of nicotinic acetylcholine receptor channel in mouse skeletal muscles. |
2000 |
Brain Res. |
pmid:10661520
|
Ram A et al. |
CSF levels of prostaglandins, especially the level of prostaglandin D2, are correlated with increasing propensity towards sleep in rats. |
1997 |
Brain Res. |
pmid:9098570
|
Koppal T et al. |
Cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells. |
2000 |
Brain Res. |
pmid:10837804
|
Ou Z et al. |
Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2--mediated protection of brain after experimental cerebral ischemia in rat. |
2006 |
Brain Res. |
pmid:16725118
|
Toth P et al. |
Administration of human chorionic gonadotropin affects sleep-wake phases and other associated behaviors in cycling female rats. |
1994 |
Brain Res. |
pmid:7987667
|
Fowler JC et al. |
Prostaglandins block a Ca2+-dependent slow spike afterhyperpolarization independent of effects on Ca2+ influx in visceral afferent neurons. |
1985 |
Brain Res. |
pmid:2412652
|
Higashida H et al. |
Facilitation of synaptic transmission by prostaglandin D2 at synapses between NG108-15 hybrid and muscle cells. |
1984 |
Brain Res. |
pmid:6324947
|
Seregi A et al. |
The formation and regional distribution of prostaglandins D2 and F2 alpha in the brain of spontaneously convulsing gerbils. |
1985 |
Brain Res. |
pmid:3859353
|
Seregi A et al. |
Decreased levels of brain cyclo-oxygenase products as a possible cause of increased seizure susceptibility in convulsion-prone gerbils. |
1984 |
Brain Res. |
pmid:6430471
|
Suzuki F et al. |
Transport of prostaglandin D2 into brain. |
1986 |
Brain Res. |
pmid:3465420
|
Hirata Y et al. |
Anti-apoptotic and pro-apoptotic effect of NEPP11 on manganese-induced apoptosis and JNK pathway activation in PC12 cells. |
2004 |
Brain Res. |
pmid:15342272
|
Watanabe Y et al. |
Specific bindings of prostaglandin D2, E2 and F2 alpha in postmortem human brain. |
1985 |
Brain Res. |
pmid:2994820
|
Kadekaro M et al. |
Central interactions between angiotensin II and PGD(2) in the regulation of vasopressin and oxytocin secretion in dehydrated rats. |
2001 |
Brain Res. |
pmid:11166690
|
Tokumoto H et al. |
Specificity of prostaglandin D2 binding to synaptic membrane fraction of rat brain. |
1986 |
Brain Res. |
pmid:2867812
|
Uda R et al. |
Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice. |
1990 |
Brain Res. |
pmid:2322844
|
Watanabe Y et al. |
Modulation by prostaglandin D2 of mitral cell responses to odor stimulation in rabbit olfactory bulb. |
1986 |
Brain Res. |
pmid:2873871
|
Drew PD et al. |
Hormone regulation of microglial cell activation: relevance to multiple sclerosis. |
2005 |
Brain Res. Brain Res. Rev. |
pmid:15850670
|
Koyama Y and Hayaishi O |
Modulation by prostaglandins of activity of sleep-related neurons in the preoptic/anterior hypothalamic areas in rats. |
1994 |
Brain Res. Bull. |
pmid:8124575
|
Gibbons H et al. |
Hypothermia suppresses inducible nitric oxide synthase and stimulates cyclooxygenase-2 in lipopolysaccharide stimulated BV-2 cells. |
2003 |
Brain Res. Mol. Brain Res. |
pmid:12573534
|
Liu H et al. |
PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro. |
2003 |
Breast Cancer Res. Treat. |
pmid:12779083
|
Yee LD et al. |
The antiproliferative effects of PPARgamma ligands in normal human mammary epithelial cells. |
2003 |
Breast Cancer Res. Treat. |
pmid:12725418
|
Kamagata C et al. |
15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression. |
2007 |
Breast Cancer Res. Treat. |
pmid:17028981
|
Holgate ST |
The role of mast cells in the pathogenesis of asthma. |
1985 Sep-Oct |
Bull Eur Physiopathol Respir |
pmid:2415192
|
Petrova LN et al. |
Effect of prostaglandins E2 and D2 on presynaptic NMDA receptors in rat cerebral cortex. |
2007 |
Bull. Exp. Biol. Med. |
pmid:18457019
|
Imanishi J et al. |
[Inhibition of the multiplication of human herpes virus I by prostaglandin D2 and the synergistic effect of human leukocyte interferon]. |
1984 |
C. R. Seances Soc. Biol. Fil. |
pmid:6100083
|
Takagi T et al. |
Effect of prostaglandin D2 on the femoral bone mineral density in ovariectomized rats. |
1993 |
Calcif. Tissue Int. |
pmid:8369992
|
Maurin AC et al. |
Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids. |
2005 |
Calcif. Tissue Int. |
pmid:15868283
|
Sato T et al. |
Decreased hypothalamic prostaglandin D2 and prostaglandin E2 contents during isoflurane anaesthesia in rats. |
1995 |
Can J Anaesth |
pmid:8590493
|
Liao CH et al. |
Antiplatelet effect of demethyldiisoeugenol. |
1996 |
Can. J. Physiol. Pharmacol. |
pmid:9022830
|
Coe JY et al. |
A fetal-instrumented model to study age-specific responses to leukotriene D4 and prostaglandin D2 in unsedated newborn lambs. |
1989 |
Can. J. Physiol. Pharmacol. |
pmid:2776077
|
Larsen P et al. |
Calcium-stimulated short-circuit currents in the canine proximal colonic epithelium: effects of DK-PGD2, a metabolite of prostaglandin D2. |
2002 |
Can. J. Physiol. Pharmacol. |
pmid:12489928
|
Liu J et al. |
Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells. |
2005 |
Cancer Chemother. Pharmacol. |
pmid:15838654
|
Nagata D et al. |
Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer. |
2008 |
Cancer Detect. Prev. |
pmid:18789607
|
Sabichi AL et al. |
Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells. |
2004 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:15533896
|
Subbarayan V et al. |
Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells. |
2004 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:15533897
|
Fu YG et al. |
Inhibition of gastric cancer cells associated angiogenesis by 15d-prostaglandin J2 through the downregulation of angiopoietin-1. |
2006 |
Cancer Lett. |
pmid:16412567
|
Cesario RM et al. |
Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer. |
2006 |
Cancer Lett. |
pmid:16271436
|
Qiao L et al. |
Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2. |
2008 |
Cancer Lett. |
pmid:18477501
|
Tan BS et al. |
6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ). |
2013 |
Cancer Lett. |
pmid:23612072
|
Núñez NP et al. |
PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells. |
2006 |
Cancer Lett. |
pmid:15979236
|
Sakai T et al. |
Prostaglandin D2 inhibits the proliferation of human neuroblastoma cells. |
1983 |
Cancer Lett. |
pmid:6572553
|
Siavash H et al. |
Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells. |
2004 |
Cancer Lett. |
pmid:15194221
|
Hawcroft G et al. |
Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells. |
2004 |
Cancer Lett. |
pmid:15172124
|
Tippin BL et al. |
Intestinal tumor suppression in ApcMin/+ mice by prostaglandin D2 receptor PTGDR. |
2014 |
Cancer Med |
pmid:24729479
|
Chen F |
Endogenous inhibitors of nuclear factor-kappaB, an opportunity for cancer control. |
2004 |
Cancer Res. |
pmid:15548674
|
Atsmon J et al. |
Conjugation of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion. |
1990 |
Cancer Res. |
pmid:2306739
|
Sakai T et al. |
Protection by cycloheximide against cytotoxicity induced by vincristine, colchicine, or delta 12-prostaglandin J2 on human osteosarcoma cells. |
1989 |
Cancer Res. |
pmid:2917351
|
Chiabrando C et al. |
Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor. |
1987 |
Cancer Res. |
pmid:3100032
|
McClay EF et al. |
delta 12-Prostaglandin-J2 is cytotoxic in human malignancies and synergizes with both cisplatin and radiation. |
1996 |
Cancer Res. |
pmid:8752147
|
Rubin GL et al. |
Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy. |
2000 |
Cancer Res. |
pmid:10749129
|
Houston KD et al. |
Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma. |
2003 |
Cancer Res. |
pmid:12649180
|
Yang VW et al. |
Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. |
1998 |
Cancer Res. |
pmid:9563494
|
Vanaja DK et al. |
Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-delta12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells. |
2000 |
Cancer Res. |
pmid:10987274
|
Abdel-Malek ZA et al. |
In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandins. |
1987 |
Cancer Res. |
pmid:2438034
|
Ishioka C et al. |
Inhibitory effects of prostaglandin A2 on c-myc expression and cell cycle progression in human leukemia cell line HL-60. |
1988 |
Cancer Res. |
pmid:3162825
|
Iwanaga K et al. |
Mast cell-derived prostaglandin D2 inhibits colitis and colitis-associated colon cancer in mice. |
2014 |
Cancer Res. |
pmid:24879565
|
Kim J et al. |
Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products. |
2005 |
Cancer Res. |
pmid:16024620
|
Park JM et al. |
Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice. |
2007 |
Cancer Res. |
pmid:17283118
|
Kim HJ et al. |
15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain. |
2007 |
Cancer Res. |
pmid:17363578
|
Bregman MD et al. |
Inhibition of human melanoma growth by prostaglandin A, D, and J analogues. |
1986 |
Cancer Res. |
pmid:3698005
|
Kato T et al. |
Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo. |
1986 |
Cancer Res. |
pmid:3708585
|
Shimakura S and Boland CR |
Eicosanoid production by the human gastric cancer cell line AGS and its relation to cell growth. |
1992 |
Cancer Res. |
pmid:1551103
|
Badawi AF et al. |
Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. |
2004 |
Cancer Res. |
pmid:14871855
|
Bhuyan BK et al. |
Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture. |
1986 |
Cancer Res. |
pmid:3456266
|
Kikuchi Y et al. |
Inhibition of human ovarian cancer cell growth in vitro and in nude mice by prostaglandin D2. |
1986 |
Cancer Res. |
pmid:3458525
|
Avis I et al. |
Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition. |
2005 |
Cancer Res. |
pmid:15899809
|
Grau R et al. |
Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. |
2004 |
Cancer Res. |
pmid:15289320
|
Chinery R et al. |
Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. |
1999 |
Cancer Res. |
pmid:10364000
|
Desmond JC et al. |
The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. |
2003 |
Cancer Res. |
pmid:12543809
|
Zimmer M et al. |
The connectivity map links iron regulatory protein-1-mediated inhibition of hypoxia-inducible factor-2a translation to the anti-inflammatory 15-deoxy-delta12,14-prostaglandin J2. |
2010 |
Cancer Res. |
pmid:20354189
|
Qin C et al. |
Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells. |
2003 |
Cancer Res. |
pmid:12615709
|
Davies NJ et al. |
AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effects. |
2009 |
Cancer Res. |
pmid:19487289
|
Park EY et al. |
Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer. |
2004 |
Cancer Res. |
pmid:15150131
|
Kobayashi Y et al. |
Syntheses of 2,6-dideoxy-6-fluoro-2-[(3R and 3S)-3- hydroxytetradecanamido]-3-O-[(3R)-3-(tetradecanoyloxy)tetra decanoyl]-D- glucopyranose 4-(dihydrogen phosphate) and 2-deoxy-2-[(3R and 3S)-3- hydroxytetradecanamido]-3-O-[(3R)-3-(tetradecanoyloxy)tetra decanoyl]- alpha-D-glucopyranosyl fluoride 4-(dihydrogen phosphate): fluorosugar analogues of GLA-60. |
1991 |
Carbohydr. Res. |
pmid:1813114
|
Carlson LM et al. |
Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma. |
2013 |
Carcinogenesis |
pmid:23349014
|
Millán O et al. |
Potentiation of tumor formation by topical administration of 15-deoxy-delta12,14-prostaglandin J2 in a model of skin carcinogenesis. |
2006 |
Carcinogenesis |
pmid:16113051
|
Pavan L et al. |
Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process. |
2003 |
Carcinogenesis |
pmid:12807721
|
Kim DH et al. |
15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS. |
2009 |
Carcinogenesis |
pmid:19136476
|
Clay CE et al. |
Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells. |
1999 |
Carcinogenesis |
pmid:10506103
|
Kim EH et al. |
15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS. |
2008 |
Carcinogenesis |
pmid:18192694
|
Viñals M et al. |
Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages. |
2005 |
Cardiovasc. Res. |
pmid:15769457
|
Yuan Z et al. |
Peroxisome proliferation-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis. |
2003 |
Cardiovasc. Res. |
pmid:14499870
|
Ramji DP |
Growth hormone-releasing peptides, CD36, and stimulation of cholesterol efflux: cyclooxygenase-2 is the link. |
2009 |
Cardiovasc. Res. |
pmid:19520704
|
Tomita H et al. |
Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells. |
2005 |
Cardiovasc. Res. |
pmid:15949477
|
Bujold K et al. |
CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages. |
2009 |
Cardiovasc. Res. |
pmid:19377069
|
Qiu H et al. |
Cardiac-generated prostanoids mediate cardiac myocyte apoptosis after myocardial ischaemia. |
2012 |
Cardiovasc. Res. |
pmid:22707158
|
Chatterjee PK et al. |
The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure. |
2004 |
Cardiovasc. Res. |
pmid:14962493
|